Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Europe Opens Higher, But Vaccine And Covid-Variant Concerns Cap Gains

Published 08/02/2021, 08:58
UK100
-
DJI
-
DE40
-
AZN
-

At the start of a slightly quieter week when it comes to data, the European markets continued to ignore the rampant spread of the various covid variants, instead clinging onto their hopes that Biden will force through his fat stimulus package in the coming weeks.

Though in the green, the FTSE was pretty timid after the bell. A 0.2% increase just about kept the UK index above 6,500, a price it has struggled to move beyond in the last week or so.

The FTSE is being pinned back by concerns over the efficacy of the AstraZeneca PLC (LON:AZN)/Oxford vaccine, both in over-65s – a claim that has been challenged due to small sample sizes – and against the South African variant. South Africa has gone as far as suspending use of the vaccine, after a study showed it offered ‘minimal protection’ against the strain.

The UK index wasn’t alone in its timidity. The DAX also only added 0.2%; however, it is worth noting the German bourse is in a very different situation to its British peer.

Hovering a few points shy of 14,100, the DAX is essentially at an all-time high; the FTSE, on the other hand, is 400 points off its January peak, and 1,300 adrift of its own personal best.

Looking ahead to this afternoon and the Dow Jones finds itself in a similar situation to the DAX. Also facing a 0.2% increase, the Dow is in all-time high territory. Further positive progress from the Biden administration regarding its $1.9 trillion stimulus package, and the US index could be breaking records in no time.

"Disclaimer: Spreadex provides an execution only service and the comments above do not constitute (or should not be construed as constituting) investment advice or recommendations, or a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any person placing trades based on their interpretations of the above comments does so entirely at their own risk. Spreadex Ltd is a financial and sports spread betting and sports fixed odds betting firm, which specialises in the personal service and credit area. Founded in 1999, Spreadex is recognised as one of the longest established spread betting firms in the industry with a strong reputation for its high level of customer service and account management.

In relation to spread betting, Spreadex Ltd is authorised and regulated by the Financial Conduct Authority. Spread betting carries a high level of risk to your capital and can result in losses larger than your initial stake/deposit. It may not be suitable for everyone, so please ensure you fully understand the risks involved."

Original Post

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.